SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program BEIJING, July 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Health Bureau as the sole supplier of inactivated hepatitis A vaccine in pre-filled syringe dosage] [Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu BEIJING, July 23, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention ("Beijing CDC") to be a supplier of the seasonal influenza vaccine to the citizens] [Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results BEIJING, July 25, 2014 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. The Company] []

By | 2016-03-16T07:03:33+00:00 August 19th, 2014|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Read More

HMIN [Homeinns Hotel] CORRESP: (Original Filing)

[HOME INNS & HOTELS MANAGEMENT INC. No. 124 Caobao Road Xuhui District Shanghai 200235 People’s Republic of China August 19, 2014 VIA EDGAR Kevin Woody, Branch Chief Shannon Sobotka, Staff Accountant Angela McHale, Senior Counsel Division of Corporation Finance 100 F Street, N.E. Re: Home Inns & Hotel Management Inc. (the “Company”) Form 20-F for Fiscal Year Ended December 31,]

By | 2016-03-27T21:55:54+00:00 August 19th, 2014|Categories: Chinese Stocks, HMIN, SEC Original|Tags: , , , , , |0 Comments
Read More

GSI [GENERAL STEEL] 10-Q/A: (Original Filing)

[EXPLANATORY NOTE This Amendment No. 1 restates the following items: · Part I, Item 1 – Unaudited Financial Statements - Notes 2 and 3 (h) · Part I, Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations. · Part I, Item 4 – Controls and Procedures. This Amendment No. 1 contains restatements related to the] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zuosheng Yu, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, John Chen, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 19, 2014 Zuosheng Yu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 19, 2014 John Chen Chief Financial Officer]

By | 2016-04-02T15:44:07+00:00 August 19th, 2014|Categories: Chinese Stocks, GSI, SEC Original|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: Sinovac Receives Tender to Supply Inactivated Hepatitis A

[Sinovac Receives Tender to Supply Inactivated Hepatitis A Vaccine Healive in Beijing Under Expanded Immunization Program BEIJING, July 21, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Health Bureau as the sole supplier of inactivated hepatitis A vaccine in pre-filled syringe dosage] [Sinovac Receives Beijing CDC Tender to Supply Seasonal Flu Vaccine Anflu BEIJING, July 23, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention ("Beijing CDC") to be a supplier of the seasonal influenza vaccine to the citizens] [Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results BEIJING, July 25, 2014 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2014, after market close on Thursday, August 14, 2014 EDT. The Company] []

By | 2016-03-16T07:04:47+00:00 August 19th, 2014|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

HMIN [Homeinns Hotel] CORRESP: HOME INNS & HOTELS MANAGEMENT INC. No. 124

[HOME INNS & HOTELS MANAGEMENT INC. No. 124 Caobao Road Xuhui District Shanghai 200235 People’s Republic of China August 19, 2014 VIA EDGAR Kevin Woody, Branch Chief Shannon Sobotka, Staff Accountant Angela McHale, Senior Counsel Division of Corporation Finance 100 F Street, N.E. Re: Home Inns & Hotel Management Inc. (the “Company”) Form 20-F for Fiscal Year Ended December 31,]

By | 2016-03-27T21:57:24+00:00 August 19th, 2014|Categories: Chinese Stocks, HMIN, Webplus ver|Tags: , , , , , |0 Comments
Read More

GSI [GENERAL STEEL] 10-Q/A: EXPLANATORY NOTE This Amendment No. 1 restates the

[EXPLANATORY NOTE This Amendment No. 1 restates the following items: · Part I, Item 1 – Unaudited Financial Statements - Notes 2 and 3 (h) · Part I, Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations. · Part I, Item 4 – Controls and Procedures. This Amendment No. 1 contains restatements related to the] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Zuosheng Yu, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material] [18 U.S.C. SECTION 1350, SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, John Chen, certify that: 1. I have reviewed this Amendment No. 1 to the quarterly report on Form 10-Q/A of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 19, 2014 Zuosheng Yu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 19, 2014 John Chen Chief Financial Officer]

By | 2016-04-02T15:45:47+00:00 August 19th, 2014|Categories: Chinese Stocks, GSI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: (Original Filing)

[-- Conference call scheduled for Friday, August 15, 2014 at 8:00 AM ET -- BEIJING, Aug.14, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2014. Second Quarter 2014 Financial Highlights compared to the second quarter] []

By | 2016-03-16T07:05:41+00:00 August 19th, 2014|Categories: Chinese Stocks, SEC Original, SVA|Tags: , , , , , |0 Comments
Read More

CNET [ChinaNet Online] 10-Q: (Original Filing)

[o x 19 s As of August TABLE OF CONTENTS PART I. FINANCIAL INFORMATION PAGE Item 1. Interim Financial Statements Consolidated Balance Sheets as of June 30, 2014 (Unaudited) and December 31, 2013 F1-F2 Consolidated Statements of Operations and Comprehensive (Loss)/Income for the Six and Three Months Ended June 30, 2014 and 2013 (Unaudited) F3-F4 Consolidated Statements of Cash Flows] [CERTIFICATION I, Handong Cheng, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATION I, Zhige Zhang certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of ChinaNet Online Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. August 19, 2014 Handong Cheng Chief Executive Officer Zhige Zhang Chief Financial Officer (Principal Accounting and Financial Officer)]

By | 2016-03-29T22:44:21+00:00 August 19th, 2014|Categories: Chinese Stocks, CNET, SEC Original|Tags: , , , , , |0 Comments
Read More

GSI [GENERAL STEEL] 10-K/A: (Original Filing)

[EXPLANATORY NOTE This Amendment No. 1 restates the following items: · Part II, Item 7 – Management’s Discussion and Analysis of Financial Condition and Result of Operations; · Part II, Item 8 – Financial Statements and Supplementary Data - Notes 2, 3(c), 3(i), 17 and 26; · Part II, Item 9A – Controls and Procedures; and · This Amendment No.] [Subsidiary Percentage General Steel Investment Co., Ltd. British Virgin Islands 100.0 % General Steel (China) Co., Ltd. P.R.C. 100.0 % Baotou Steel – General Steel Special Steel Pipe Joint Venture Co., Ltd. P.R.C. 80.0 % Yangpu Shengtong Investment Co., Ltd. P.R.C. 99.1 % Tianjin Qiu Steel Investment Co., Ltd. P.R.C. 98.7 % Shaanxi Longmen Iron and Steel Co., Ltd. P.R.C.] [Certification I, Zuosheng Yu, certify that: 1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [Certification I, John Chen, certify that: 1. I have reviewed this Amendment No. 1 to the Annual Report on Form 10-K of General Steel Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Zuosheng Yu Chief Executive Officer August 19, 2014 John Chen Chief Financial Officer (Principal Financial Officer) August 19, 2014]

By | 2016-04-02T15:50:24+00:00 August 19th, 2014|Categories: Chinese Stocks, GSI, SEC Original|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] 6-K: — Conference call scheduled for Friday, August 15,

[-- Conference call scheduled for Friday, August 15, 2014 at 8:00 AM ET -- BEIJING, Aug.14, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2014. Second Quarter 2014 Financial Highlights compared to the second quarter] []

By | 2016-03-16T07:06:52+00:00 August 19th, 2014|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar